Initial experience with norepinephrine infusion in hypotensive critically III foals

Journal of Veterinary Emergency and Critical Care

Volumn 10, Issue 4, 2000, Pages 267-276

  Corley, Kevin T ^a   McKenzie, Harold C ^a   Amoroso, Lisa M ^a   Furr, Martin O ^a  

^a MARION DUPONT SCOTT EQUINE MEDICAL CENTER   (United States)

Author keywords

Dobutamine; Foal; Hypotension; Norepinephrine; Urine output

Indexed keywords

EID: 0001640878     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2000.tb00012.x     Document Type: Article

References (32)

1. Hollenberg SM, Ahrens TS, Astiz ME, et al. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 27:639–660, 1999.
2. Martin C, Viviand X, Arnaud S, et al. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients. Crit Care Med 27:1708–1713, 1999.
3. Cohen ND. Causes of and farm management factors associated with disease and death in foals. J Am Vet Med Assoc 204:1644–1651, 1994.
4. st ed. Ed by AM Koterba, WH Drummond, PC Kosch. Philadelphia, Lea and Febiger, 1990, pp 106–123.
5. Furr M. Perinatal asphyxia in foals. Compend Contin Educ Pract Vet 18:1342–1351, 1997.
6. Martin C, Saux P, Eon B, et al. Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesth Scand 34:413–417, 1990.
7. st ed. Ed by AM Koterba, WH Drummond, PC Kosch. Philadelphia, Lea and Febiger, 1990, pp 295–316.
8. Furr M, Tinker MK, Edens L. Prognosis for neonatal foals in in intensive care unit. J Vet Int Med 11:183–188, 1997.
9. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655, 1992.
10. Kirby R. Septic Shock. In: Kirk's Current Veterinary Therapy. 12 ed. Ed by JD Bonagura, RW Kirk. Philadelphia, W.B. Saunders, 1995, pp 139–146.
11. Thomas WP, Madigan JE, Backus KQ, et al. Systemic and pulmonary haemodynamics in normal neonatal foals. J Reprod Fert Suppl. 35:623–628, 1987.
12. Parker MM, Shelhamer JH, Natanson C, et al. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15:923–929, 1987.
13. Lavoie JP, Madigan JE, Cullor JS, et al. Haemodynamic, pathological, haematological and behavioural changes during endotoxin infusion in equine neonates. Equine Vet J 22:23–29, 1990.
14. Bottoms GD, Fessler JF, Roesel OF, et al. Endotoxin-induced hemodynamic changes in ponies: effects of flunixin meglumine. Am J Vet Res 42:1514–1518, 1981.
15. Clark ES, Gantley B, Moore JN. Effects of slow infusion of a low dosage of endotoxin on systemic haemodynamics in conscious horses. Equine Vet J 23:18–21, 1991.
16. Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock Chest 103:1826–1831, 1993.
17. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. J Am Med Assoc 272:1354–1357, 1994.
18. King JN, Gerring EL. Biphasic disruption of fasting equine gut motility by dopamine—a preliminary study. J Vet Pharmacol Therap 11:354–361, 1988.
19. Wood K, Connery L, Coursin DB. Perioperative multiple organ dysfunction syndrome. Semin Anesth Perioper Med Pain 18:27–43, 1999.
20. Martin C, Perrin G, Saux P, et al. Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med 20:444–447, 1994.
21. Cronin RE, Erickson AM, de Torrente A, et al. Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure. Kidney Int 14:187–190, 1978.
22. Bellomo R, Kellum JA, Wisniewski SR, et al. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 159:1186–1192, 1999.
23. Desjars P, Pinaud M, Potel G, et al. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 15:134–137, 1987.
24. Martin C, Eon B, Saux P, et al. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18:282–285, 1990.
25. Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 13:492–496, 1985.
26. Richer M, Robert S, Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 24:1150–1156, 1996.
27. Hoogenberg K, Smit AJ, Girbes AR. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 26:260–265, 1998.
28. Juste RN, Panikkar K, Soni N. The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intensive Care Med 24:564–568, 1998.
29. Duranteau J, Sitbon P, Teboul JL, et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27:893–900, 1999.
30. Goncalves JA, Hydo LJ, Barie PS. Factors influencing outcome of prolonged norepinephrine therapy for shock in critical surgical illness. Shock 10:231–236, 1998.
31. Rigal JC, Blanloeil Y, Theolat M, et al. Survival and quality-of-life of patients with septic shock requiring epinephrine or norepinephrine. Br J Anaesth 82:A569, 1999.
32. Gayle JM, Cohen ND, Chaffin MK. Factors associated with survival in septicemic foals: 65 cases (1998–1995). J Vet Int Med 12:140–146, 1998.